Iris Brummelhuis

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt et al. · European Urology · 2019 · 189 citations · Full text

EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

Alan Horwich, Marek Babjuk, Joaquim Bellmunt et al. · Annals of Oncology · 2019 · 180 citations · Full text

Urology, Genitourinary Cancer, Eau–esmo Consensus Statements +7

DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer

F. Johannes P. van Valenberg, Iris Brummelhuis, Lars H. Lindner et al. · International Journal of Nanomedicine · 2021 · 29 citations · Full text

The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial

Siamak Daneshmand, Iris Brummelhuis, Kamal S. Pohar et al. · Urologic Oncology Seminars and Original Investigations · 2022 · 29 citations · Full text

Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer

Iris Brummelhuis, Yvonne Wimper, Hilde G. J. M. Witjes-van Os et al. · Cancers · 2021 · 26 citations · Full text